Trachyostracous mussel extract and its preparation and use

A technology of thick-shelled mussels and extracts, applied in the direction of medical preparations containing active ingredients, drug combinations, pharmaceutical formulas, etc., to enhance the transformation ability of B lymphocytes, enhance the humoral immune function, and increase the transformation ability of T lymphocytes Effect

Inactive Publication Date: 2009-03-11
SHANGHAI CENT OF RES & DEV OF NEW DRUGS
View PDF5 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no report on the use of mussel substances in new drugs at home and abroad

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Trachyostracous mussel extract and its preparation and use
  • Trachyostracous mussel extract and its preparation and use
  • Trachyostracous mussel extract and its preparation and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] The preparation of the extract of embodiment 1 thick shell mussel

[0037]Collect fresh thick-shelled mussels with bright shells and roughly equal individual size and weight from the Zhoushan Islands in Zhejiang Province, my country, wash, shell, and wash away the sediment. Store in -20°C refrigerator. Take out the preserved thick-shelled mussels, thaw, boil for 1-2 hours, filter out the dry matter, and homogenize. Adjust the pH of the raw material slurry to 6.0, add 0.1% (ratio to raw material) Neutrase enzyme produced by Danish Novozymes, 45 ° C, stir for 3 hours; then boil, adjust the pH to 6.8, add 1% (ratio to raw material) Flavourzyme enzyme, 50 ℃, stirred for 3h, boiled. Obtain a hydrolyzate. Dilute the obtained hydrolyzate by 10 times, remove impurities with an ion exchange column equipped with weakly basic resin D303, and obtain a crude product with a pH of about 5.0. Concentrate the obtained crude product in a rotary vacuum concentrator at 50° C. to an ext...

Embodiment 2

[0038] Embodiment 2 The selection of mussel raw material

[0039] Raw materials were purchased from different origins. It is prepared into freeze-dried powder, or frozen after being shelled. Samples were prepared by the established production process, and the amino N, total N and in vivo activity were determined. Compare the advantages and disadvantages of each raw material, as shown in Table 1.

[0040] Table 1 Selection of mussel raw materials

[0041]

[0042] Note: Meat yield = weight of fresh shellfish / weight of shellfish. Dry matter content = weight of dry matter / weight of fresh shellfish. Dry the fresh scallops at a constant temperature of 60°C, constant weight three times, and weigh.

[0043] The total nitrogen content in dry matter and acid hydrolyzed solution was significantly higher in mussels. The samples prepared from dried mussels, emerald mussels and thick-shelled mussels were tested for the in vivo activity of the mouse influenza virus m...

Embodiment 3

[0044] Example 3 Determination of amino acid content in samples

[0045] Get the extract of Example 1, measure and measure the amino acid content according to the commonly used RP-HPLC and OPA method in the art (Edited by Xia Qichang, "Protein Chemistry Research Technology and Progress", Beijing: Science Press, 1999: 30-32.) , the result is amino acid 12.5g / 100mL extract.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to medicine preparation with animal material, and is especially trachyostracous mussel extract and its preparation and use. The trachyostracous mussel extract features its total nitrogen content of 12-16 mg / ml, protein concentration of 15-20 mg / ml, amino nitrogen content of 8.5-15 mg / ml and pH 5.0-6.0. The preparation process includes washing trachyostracous mussel, eliminating shell, homogenizing meat to form homogeneous slurry, hydrolysis, eliminating acid and impurity with weak alkaline resin, concentration and other steps. The trachyostracous mussel extract of the present invention may be used in preparing medicines for resisting influenza, resisting SARS and regulating immunity.

Description

technical field [0001] The present invention belongs to the field of medical preparations containing raw materials from animals other than mammals or birds or the extracts of their reaction products with unknown structures, in particular to the extract, production method and pharmaceutical application of thick-shelled mussels Applications. Background technique [0002] The ocean is a huge treasure house of medicine sources. So far, more than 1,000 new compounds have been obtained from marine animals and plants, more than half of which have pharmacological activities such as antitumor, antibacterial, and antiviral. The study of marine drugs has become the trend of modern biomedical research. Compared with other shellfish, mussels have high yield and low price. Mussel, synonym: shell vegetable, sea red, red clam, etc., Latin name: Mytilus edulis; English name: mussel. The main species are: 1. Blue mussel (Mytilus galloprovincilis Linaeus), which lives on rocky reefs near t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K35/56A61P11/10A61P29/00A61P43/00A61K35/618
Inventor 唐军汪兰英张灵霞杨秀珍
Owner SHANGHAI CENT OF RES & DEV OF NEW DRUGS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap